Update
$VistaGen Therapeutics (VTGN.US)$ Vistagen Announces Positive Results From Phase 2a Pilot Study of Ph15 for Improvement of Psychomotor Impairment Caused by Mental Fatigue. Vistagen Therapeutics Inc: Ph15 Was Safe and Well-Tolerated With an Adverse Event Profile Similar to Placebo
Disclaimer: Community is offered by Moomoo Technologies Inc. and is for educational purposes only.
Read more
Comment
Sign in to post a comment
沒虧錢就是贏家 : How high chance flying?
Trytosaveabit OP 沒虧錢就是贏家 : Not sure! Gotta see what volume/interest it gets?
沒虧錢就是贏家 Trytosaveabit OP : strange movement dropping
Trytosaveabit OP 沒虧錢就是贏家 : No volume
沒虧錢就是贏家 : Is the vol 54mil on 7Aug23 real? Total issue shares only 27mil